Search

You searched for "Climate"

1107 results found
Cornea journal cover image.

Platelet rich fibrin membrane for descemetocele

1 December 2016 | | EYE - Cornea, EYE - General
This case series described the use of a novel technique in the treatment of descemetocele. Three patients developed descemetoceles following infective keratitis with impending risk of corneal perforation. Platelet rich fibrin (PRF) membrane was prepared using 8ml of fresh venous...

Impact of medical vs. surgical treatment on quality of life in glaucoma patients

1 December 2013 | | EYE - Glaucoma
The author recruited 225 patients across two sites and divided them into three groups. Group 1 medical treatment only, Group 2 surgical treatment only, Group 3 mixed medical and surgical (patients still on drops after surgery). They then used a...
Neuro-ophthalmology front cover image.

Using optical coherence tomography angiography to detect MoyaMoya vasculopathy

5 April 2022 | | EYE - Neuro-ophthalmology | Neuro-ophthalmology, moyamoya vasculopathy, optical coherence tomography angiography, retina
Moyamoya (MM) disease is a chronic cerebrovascular disease that can lead to progressive stenosis of the terminal portions of the internal carotid arteries and their proximal branches. The authors carried out a cross-sectional cohort study to investigate vascular changes in...
Pediatric Ophthalmology & Strabismus journal cover

Exotropic angle by PACT vs under translucent cover

5 August 2022 | | EYE - Paediatrics, EYE - Strabismus
The authors aimed to validate the photographic analysis with a translucent cover by comparing the results obtained from this analysis with the angle obtained by prism cover test (PACT) in patients with intermittent exotropia. This was a retrospective review of...
JAAPOS journal cover image.

Proof of concept for using aqueous humour to detect retinoblastoma variant

1 September 2023 | | EYE - Paediatrics, EYE - Strabismus
A proof of concept study is presented with the aim of assessing the feasibility of using aqueous humour surrogate marker for tumour tissue for identifying retinoblastoma RB1 variant. Three children undergoing enucleation for retinoblastoma were recruited from a single centre....

Reviews

Toxoplasmosis and the associated retinochoroiditis: important facts and when to treat

1 April 2017 | | EYE - Vitreo-Retinal
Annie SeeWah Tung provides an overview of toxoplasmosis retinochoroiditis, including guidance on which cases should be treated and the treatment options. Toxoplasmosis retinochoroiditis is an infectious condition that is characterised by retinochoroidal lesions commonly in the posterior pole and is...

Building a resonant personal brand: A 10-step guided path for ophthalmologists

4 December 2024 | | EYE - General
Here are 10 actionable steps to carve out a meaningful personal brand. 1. Uncover your core values Delve into the ethos and values that define you as a professional. What sets you apart in the ophthalmic arena? These will be...

Blind veterans continue hillwalking passion thanks to power of VR

13 April 2023 | vr, virtual reality, visual impairment, Assistive technology
Imagine being a keen hillwalker who loves the outdoors but then being unable to enjoy it because of sight loss. Fortunately, many veterans of the Armed Forces who have visual impairment can climb their favourite mountains again, thanks to Sight Scotland Veterans.

The 2020 Milgram Experiment

19 May 2020 | | EYE - General
Will ophthalmology recover from COVID-19? Learning Curve columnist Gwyn Samuel Williams shares his thoughts on the developing impact of the pandemic “It’s busy today,” the nurse in green chuckles. “There are six patients I think.” Six. This clinic is designed...

The Global Vision Database

1 December 2015 | | EYE - General
The overall goal of the Global Vision Database (GVD) [1] is to develop and deploy new and improved evidence on the prevalence of blindness and vision impairment (VI) globally. It is a repository which allows us to assess the causes...

Regulatory drug evaluations and expedited review initiatives: EU and US perspectives

1 April 2016 | | EYE - General
The European Medicines Agency (EMA) and United States Food and Drug Administration (FDA) each conduct independent assessments of benefit-risk profile when evaluating applications to market new or modified medicines, and their respective decision-making is guided by distinct legislation, procedures and...